Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for cardiovascular event risk reduction in high-risk cardiovascular patients
2022-003573-32Phase 3Active
- Sponsor
- Poznan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperuricemia and cardiac morbidity comparing Milurit with Placebo (2 arms). Started Dec 2022; status: active.
02
Drugs
allopurinol
03
Conditions
hyperuricemiacardiac morbidity
Beyond the preview
Go deeper on 2022-003573-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003573-32.